CYPHERPUNK TECHNOLOGIES INC. - Common Stock, par value $0.001 per share (CYPH)

Q: What does CUSIP 52187K200 represent in this 13F holders report?

CUSIP 52187K200 is the security identifier for CYPH - CYPHERPUNK TECHNOLOGIES INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held CYPH - CYPHERPUNK TECHNOLOGIES INC. - Common Stock, par value $0.001 per share in Q1 2025?

44 institutional investors reported CYPH - CYPHERPUNK TECHNOLOGIES INC. - Common Stock, par value $0.001 per share for Q1 2025. Use the holders table for investor-level position and value details.

CUSIP: 52187K200

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 16,693,179
Total 13F value: $5,091,655
Share change: -2,540,116
Put/Call ratio: 140%
SEC-reported price per share: $0.31
Number of holders: 44
Value change: -$10,873,451
Number of buys: 20
Number of sells: 37
Shares outstanding: 124,897,553

Security key

52187K200

Report period

Q1 2025

Institutions

Top holders

CYPH full security history Ownership snapshot Full 13F holder table CYPHERPUNK TECHNOLOGIES INC. SEC filings CYPHERPUNK TECHNOLOGIES INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CYPH - CYPHERPUNK TECHNOLOGIES INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BeOne Medicines Ltd.

Disclosed value leader

BeOne Medicines Ltd.

Comparable rows

0/15

Latest evidence

31 Dec 2024

3/4/5 13D/G 13F Highest disclosed value: $20,943,045 15 rows are not safely comparable across share classes. 13D/G row: BeOne Medicines Ltd. Showing 1-6 of 15 holder rows.

Quick read

BeOne Medicines Ltd. has the largest disclosed position value at $20.94M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BeOne Medicines Ltd.'s linked filing trail.

Disclosed position value Top 5

BeOne Medicines Ltd. $20.94M

GILEAD SCIENCES, INC. $15.29M

Samsara BioCapital, LLC $7.02M

Point72 Asset Management, L.P. $4.02M

683 Capital Management, LLC $3.88M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BeOne Medicines Ltd.	3/4/5 13D/G 10%+ Owner · BeiGene, Ltd. 3/4/5 13D/G	— denominator unverified	$20,943,045 7,348,437 shares	—	24 Sep 2021
GILEAD SCIENCES, INC.	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	— denominator unverified	$15,292,551 5,319,148 shares	—	31 Dec 2024
PERCEPTIVE ADVISORS LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 3,508,771 shares	—	24 Sep 2021
Samsara BioCapital, LLC	13F Company 13F	— denominator unverified	$7,021,762 2,442,352 shares	—	31 Dec 2024
Point72 Asset Management, L.P.	13F Company 13F	— denominator unverified	$4,025,000 1,400,000 shares	—	31 Dec 2024
683 Capital Management, LLC	13F Company 13F	— denominator unverified	$3,881,250 1,350,000 shares	—	31 Dec 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

16,693,179

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q1 2025 value	Value change	Value Chg %